Drug recall · December 18, 2019
Mirtazapine Tablets recall
Why: Labeling: Label Error on Declared Strength; cases labelled Mirtazapine 15mg tablets, 500-count bottles, contain 500-count bottles of Mirtazapine 15mg tablets labelled as Mirtazapine 7.5 mg tablets.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Mirtazapine Tablets, USP, 7.5 mg, 500-count tablets, Rx only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, NJ 08810 NDC 13107-001-05
- Lots / codes
Lot #: 03119002A3, Exp 3/2022
- Quantity
- N/A
- Company
- AuroMedics Pharma LLC, East Windsor, NJ
- Distribution
- Nationwide
- Initiated
- November 20, 2019 · Voluntary: Firm initiated
- Classified
- January 2, 2020
- Reported
- December 18, 2019
- Ended
- February 21, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Mirtazapine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.